Ian Woolley Selected Research

Ian Woolley Research Topics

Disease

10	Infections 10/2022 - 02/2003
6	HIV Infections (HIV Infection) 01/2021 - 01/2006
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 05/2011
3	Coinfection 10/2022 - 02/2003
3	Human Influenza (Influenza) 11/2021 - 06/2010
3	Inflammation (Inflammations) 01/2021 - 11/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2014 - 11/2004
2	Persistent Infection 03/2023 - 01/2022
2	Neoplasms (Cancer) 11/2021 - 05/2012
2	Wounds and Injuries (Trauma) 01/2020 - 05/2012
1	Reinfection 01/2022
1	Frailty 01/2022
1	Rheumatic Diseases (Rheumatism) 11/2021
1	Communicable Diseases (Infectious Diseases) 02/2019
1	Cystic Fibrosis (Mucoviscidosis) 01/2017
1	Hepatitis B 02/2016
1	Immune Reconstitution Inflammatory Syndrome 11/2015
1	Osteomyelitis 11/2015
1	Lipodystrophy 06/2015
1	Hepatitis 01/2015
1	Viremia 05/2014
1	Vitamin D Deficiency 07/2013
1	Thrombocytosis (Thrombocythemia) 01/2011
1	Lymphocytosis 01/2011
1	Hepatitis C 09/2007
1	Sepsis (Septicemia) 12/2006

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 03/2023 - 11/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2010
3	RNA (Ribonucleic Acid)IBA 01/2015 - 02/2003
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2011
2	Tenofovir (Viread)FDA Link 02/2016 - 06/2015
2	C-Reactive ProteinIBA 12/2014 - 11/2010
2	HDL LipoproteinsIBA 07/2008 - 01/2006
1	VaccinesIBA 11/2021
1	COVID-19 VaccinesIBA 11/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 11/2019
1	Fusidic Acid (Fucithalmic)IBA 11/2019
1	MacrolidesIBA 01/2017
1	FluoroquinolonesIBA 01/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017
1	abacavir (Ziagen)FDA Link 06/2015
1	LDL CholesterolIBA 06/2015
1	Vitamin D FDA LinkGeneric 07/2013
1	CytokinesIBA 07/2013
1	Complement System Proteins (Complement)IBA 05/2013
1	Immunoglobulin M (IgM)IBA 01/2011
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2010
1	InterferonsIBA 11/2010
1	fibrin fragment D (D-dimer)IBA 11/2010
1	Macrophage Migration-Inhibitory FactorsIBA 11/2010
1	Amyloid (Amyloid Fibrils)IBA 11/2010
1	Interleukin-6 (Interleukin 6)IBA 11/2010
1	Interleukin-10 (Interleukin 10)IBA 11/2010
1	Fibrinogen (Factor I)FDA Link 11/2010
1	P-SelectinIBA 11/2010
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2010
1	Cystatin CIBA 11/2010
1	RacivirIBA 11/2010
1	Lipoproteins (Lipoprotein)IBA 07/2008
1	CholesterolIBA 07/2008
1	Apolipoproteins B (ApoB)IBA 07/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2007
1	LipidsIBA 09/2007
1	AntibodiesIBA 02/2003
1	Proteins (Proteins, Gene)FDA Link 02/2003

Therapy/Procedure

6	Therapeutics 01/2022 - 05/2014
5	Splenectomy 01/2020 - 12/2006
3	Highly Active Antiretroviral Therapy (HAART) 06/2015 - 02/2003
1	Length of Stay 10/2022
1	Chemoprevention 12/2006
1	Secondary Prevention 11/2004